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Aims: To investigate the association of diabetes mellitus and impaired fasting glucose with gait in the general
middle-aged and elderly population.
Methods: We performed a cross-sectional study on 3019 participants from the population-based Rotterdam
Study (aged N45 years, 54% women). The presence of diabetes mellitus and impaired fasting glucose was
evaluated by measuring serum glucose levels and by documenting anti-diabetic treatment. Participants
underwent gait analysis using an electronic walkway. Thirty gait variables were summarized into ﬁve
independent gait domains for normal walking (Rhythm, Variability, Phases, Pace and Base of Support), one for
turning (Turning) and one for walking heel to toe (Tandem), which were averaged into Global Gait. Linear
regression analyses were performed to determine the association of diabetes, impaired fasting glucose and
continuous glucose levels within the normal range with gait.
Results: Diabetes mellitus was associated with worse Global Gait (Z-score difference −0.19, 95% conﬁdence
interval (CI) −0.30; −0.07), worse Pace (−0.20, 95% CI −0.30; −0.10) and worse Tandem (−0.21, 95% CI
−0.33; −0.09), after adjusting for age, sex, height and weight. The association with Tandem remained
signiﬁcant after additional adjustment for cardiovascular risk factors. Impaired fasting glucose and continuous
glucose levels within the normal range were not associated with any of the gait domains.
Conclusion: In our population-based study diabetes mellitus was associated with worse Global Gait, which
was mostly reﬂected in Pace and Tandem. These associations were partly driven by other cardiovascular risk
factors, emphasizing the importance of optimal control of cardiovascular risk factor proﬁles in patients
with diabetes.© 2016 Elsevier Inc. All rights reserved.1. Introduction
Diabetes mellitus is common in the elderly population and is as a
serious threat to an older person's quality of life. Complications such
as polyneuropathy, retinopathy and peripheral artery disease can
already be present at the moment of diagnosis of the disease (Raman,
Gupta, Krishna, Kulothungan, & Sharma, 2012). This suggests that
microvascular as well as macrovascular changes already occur in early
stages of diabetes and perhaps even in a state before overt diabetesof interest.
gy Erasmus University Medical
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m).develops, which is often referred to as prediabetes (Tabak, Herder,
Rathmann, Brunner, & Kivimaki, 2012). These complications directly
(neuropathy, peripheral artery disease) or indirectly (muscle weak-
ness, ulcerations, cerebrovascular disease) lead to walking instability,
falls, and fall-related injuries (Allet et al., 2008; Andersen, 2012;
England et al., 2014; Lalli et al., 2013; Raspovic, 2013; Roman de
Mettelinge, Cambier, Calders, Van Den Noortgate, & Delbaere, 2013;
Volpato & Maraldi, 2011; Volpato et al., 2012). To detect the impact of
diabetes on walking and lower limb performance in an early stage,
extensive assessment of gait in different walking conditions may be
useful (Allet et al., 2008).
Gait is a complex concept that is increasingly recognized as a
marker of general health (Studenski et al., 2011; Verlinden, van der
Geest, Hofman, & Ikram, 2014). Gait is inﬂuenced by different organ
systems, including the central and peripheral nervous system, central
and peripheral circulation and the musculoskeletal system, all of
which can be affected by diabetesmellitus. Dysfunction in any of these
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increased risk of falling and higher mortality (Verlinden et al., 2013;
Verghese, Holtzer, Lipton, & Wang, 2009). Gait can be measured using
manydifferent spatiotemporal variables,which can be summarized into
seven independent gait domains (Fig. 1): Rhythm (cadence, stride time),
Variability (variability in stride length and stride time), Phases (double
support percentage of gait cycle), Pace (stride length, velocity), Base of
Support (stride width and stride width variability) Tandem (number of
side steps in walking heel to toe) and Turning (number of steps and
turning time) (Verlinden et al., 2014, 2013).
Previous case–control studies reported lower walking speed and
cadence in individuals with diabetes (Allet et al., 2009, 2008), but
population-based data about the relation between diabetes and the gait
pattern are lacking. In addition, since microvascular pathology can be
present already early in the course of the disease (Raman et al., 2012), we
hypothesized that subtle changes in speciﬁc gait domains can not only be
found in participants with diabetes, but also in persons having only
impaired fastingglucoseorevenaglucose level in thehigh rangeofnormal.
Therefore, we aimed to investigate the association of diabetes
mellitus and prediabetes (impaired fasting glucose) with gait and its
separate domains in a community-dwelling population.2. Methods
2.1. Study setting, study design and study population
The study was embedded in the Rotterdam Study, a population-
based cohort in the Netherlands that started in 1990. At the start of
the study in 1990 and again in 2000, all people living in the Ommoord
district of Rotterdam, aged 55 years and older were selected from theRhythm (stride time)
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tandem walk (Tandem).municipal population records and invited to participate in the study.
In 2006 the cohort was extendedwith individuals that moved into the
study area, aged 45 years and older. Residential area (zip code) and
age were the only eligibility criteria used for inclusion of participants.
In total, 14,926 out of 20,744 invited persons agreed to participate in
the study (overall response rate 72%). At baseline and every 3–4 years
of follow-up, all participants undergo a home interview and extensive
medical examinations at the research center.
The Rotterdam Study has been approved by the Medical Ethics
Committee of the Erasmus MC and by the Ministry of Health, Welfare,
and Sports of the Netherlands, implementing the “Wet Bevolkingsonder-
zoek:ERGO(PopulationStudiesAct:RotterdamStudy)”.Awritten informed
consent to participate in the study and to obtain information from their
treatingphysicianswasobtained fromall participants (Hofmanet al., 2015).
FromMarch 2009 onwards, gait assessment was implemented in the
core protocol of the study. The current study includes all participants that
underwentgait assessmentbetweenMarch2009andMarch2012.During
this period 3666 persons were invited for gait measurements; after
exclusion of 600 persons (207 persons were excluded due to physical
health reasons, 296 because of technical problems, 46 participants did not
followor complete the entireprotocol, 34personshad fewer than16 steps
available for analyses, 15 had a repeated assessment and 2 persons were
excluded for other reasons), 3066 participantswere eligible for the study;
3019 of them had information about diabetes mellitus available. These
3019 participants were included in the analyses.2.2. Diabetes mellitus and impaired fasting glucose assessment
Presence of diabetes mellitus and impaired fasting glucose was
evaluated using laboratory data derived from blood sampling)
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Table 1
Population characteristics.
Characteristic Normoglycemia,
N = 1782
Impaired fasting
glucose, N = 921
Diabetes,
N = 316
Age, years 66.1 (9.2) 68.6 (8.7)⁎ 70.0 (8.2)⁎,†
Female sex, n 1,085 (60.9) 416 (45.2)⁎ 137 (43.4)⁎
Height, cm 168.6 (9.3) 169.9 (9.4) 169.5 (9.0)
Weight, kg 75.3 (13.1) 82.0 (14.4)⁎ 84.9 (14.5)⁎,†
Current cigarette smoking, n 284 (16.0) 135 (14.7) 43 (13.6)
Alcohol, grams per day 6.1 (6.7) 8.1 (8.4)⁎ 5.8 (7.5)†
Diastolic blood pressure,mmHg 82.9 (11.0) 85.4 (11.0)⁎ 84.6 (10.9)
Systolic blood pressure,mmHg 138.2 (21.7) 145.5 (21.9)⁎ 148.2 (21.8)⁎
Antihypertensivemedication,n 502 (28.2) 404 (43.9)⁎ 215 (68.3)⁎,†
Total cholesterol, mmol/L 5.6 (1.1) 5.5 (1.0) 4.8 (1.1)⁎,†
HDL-cholesterol, mmol/L 1.5 (0.4) 1.4 (0.4)⁎ 1.3 (0.4)⁎,†
Lipid loweringmedication, n 367 (20.6) 266 (28.9)⁎ 172 (54.6)⁎,†
Glucose, mmol/L 5.1 (0.4) 6.0 (0.4)⁎ 8.1 (2.3)⁎,†
Values are mean (SD) or number (%). Percentages were calculated without missing
values. Missing values occurred in less than 1%.
⁎ p-value b 0.05, impaired fasting glucose and diabetes compared to normoglycemia
age- and sex adjusted (if applicable).
† p-value b 0.05, diabetes compared to impaired fasting glucose, age- and sex
adjusted (if applicable).
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Medication use was assessed by self-report and by going through
the medication cabinets in the home of the participants during the
home interview. Diabetes was deﬁned as a fasting glucose level
≥7.0 mmol/L, a non-fasting glucose level ≥11.1 mmol/L (if fasting
samples were not available) or use of anti-diabetic therapy (Nolan,
Damm, & Prentki, 2011). Impaired fasting glucose was deﬁned
according to the ADA 2010 diagnostic criteria as a fasting glucose
level between 5.6 mmol/L and 6.9 mmol/L in the absence of diabetes
(Tabak et al., 2012).
2.3. Gait assessment
Gait was assessed using a 5.79 meter long electronic walkway
(4.88 meter of active area; GAITRite Platinum; CIR systems, Sparta, NJ,
USA), that has been validated before (Bilney, Morris, & Webster, 2003;
McDonough, Batavia, Chen, Kwon, & Ziai, 2001; Menz, Latt, Tiedemann,
Mun SanKwan, & Lord, 2004). Threewalking conditionswere recorded:
normal walk, turning and tandem walk. In normal walk, participants
were asked to walk across the electronic walkway at their own pace. In
the turn, people walked across the walkway, turned halfway, and
returned to their starting position. In tandemwalk, participants walked
heel-to-toe over a line visible on the walkway.
The walkway software was used to generate 30 different
spatiotemporal gait variables; 25 for normal walk, 2 for turning and
3 for tandem walk. Principal components analysis (PCA) was used to
summarize these 30 gait variables into independent gait domains,
while capturing the largest amount of variance. Varimax rotation was
used to make sure that the gait domains were mutually independent.
The PCA resulted in seven independent domains: Rhythm, Variability,
Phases, Pace, Base of Support, Tandem and Turning. Among others,
Rhythm represents cadence and stride time; Phases represent double
support time and double support as a percentage of the gait cycle;
Variability represents variability in stride length and stride time;
Pace represents velocity and stride length; Base of Support represents
stride width and stride width variability; Tandem represents errors
in tandem walking; and Turning represents the number of turning
steps and turning time (see Supplementary Table 1 and Fig. 1). More
details about the principal component analyses can be found
elsewhere (Verlinden et al., 2014; Verlinden et al., 2013). These
domains were standardized and, when necessary, inverted so that
lower values indicate “worse” gait. Additionally, Global Gait was
calculated by averaging the seven independent gait domains into one
standardized Z-score.
2.4. Assessment of covariates
The home interview comprised questionnaires about smoking
(current cigarette smoking versus non-smoking) and alcohol con-
sumption (converted to grams per day). Examinations at the research
center included measurement of height (in cm), weight (in kg) and
mean systolic and diastolic blood pressure from two consecutive
measurements (in mmHg). Total cholesterol and HDL-cholesterol
were measured in serum (mmol/L). Use of lipid lowering medication
(statins, ezetimibe, or ﬁbrates) and antihypertensive medication
(diuretics, calcium-channel blockers, ACE-inhibitors or beta-blockers)
was also documented during the home interview.
2.5. Statistical analysis
Weusedmultivariable linear regression analyses to investigate the
association of diabetes with Global Gait and speciﬁc gait domains.
Next, we performed analyses of impaired fasting glucose. Addition-
ally, we investigated the association of continuous glucose levels on
gait in individuals with a glucose level within the normal range and in
individuals with a normal or an impaired fasting glucose combined.All analyses were performed using two models. The ﬁrst model was
adjusted for age, sex, height and weight; the second model was
additionally adjusted for cardiovascular risk factors and medication
use (mean systolic and mean diastolic blood pressures, smoking,
alcohol use, total cholesterol, HDL-cholesterol, antihypertensive
medication and lipid lowering medication). Analyses involving
Tandem were additionally adjusted for step length and step count in
the tandem walk (Verlinden et al., 2013). Effect modiﬁcation by sex
was tested by adding an interaction term into the models. We applied
Bonferroni correction for seven tests (reﬂecting the seven indepen-
dent gait domains) to correct for multiple testing (p-value b 0.007).
We assessed potential non-linear associations for the continuous
glucose levels with gait using spline regression in R version 3.2.0. All
other reported statistical analyses were performed using the SPSS
statistical package, version 21 for Windows (IBM Corp., Armonk, NY).
3. Results
We compared population characteristics between participants and
non-participants. Results of this analyses can be found in Supple-
mentary Table 2. There were more females and more people being
treated for hypertension in the non-participants, and non-participants
were on average older.
In our sample of 3019 participants, 1782 participants (59.0%) had a
plasma glucose within the normal range, 921 participants (30.5%) had
impaired fasting glucose and 316 participants (10.5%) had diabetes.
Participants with normoglycemia were on average younger than
participants with impaired fasting glucose or diabetes. In the
normoglycemia group 60.9% was female, while this was 45.2% and
43.4% in the impaired fasting glucose and diabetes group respectively.
Normoglycemic participants had a lower weight and systolic blood
pressure and fewer people used lipid-lowering or antihypertensive
medication compared to participants with impaired fasting glucose
and diabetes (Table 1).
Diabetes mellitus was associated with worse Global Gait (differ-
ence in Z-score −0.19, 95% conﬁdence interval (CI) −0.30; −0.07)
compared to normoglycemic persons after adjustment for age, sex,
height and weight. Speciﬁcally, participants with diabetes had worse
Pace (difference in Z-score−0.20, 95% CI−0.30;−0.10) and Tandem
(difference in Z-score−0.21, 95% CI−0.33;−0.09) than participants
with normoglycemia (Fig. 2). After additional adjustment for
cardiovascular risk factors and medications, only Tandem remained
worse (difference in Z-score −0.20, 95% CI −0.33; −0.07) in
participants with diabetes compared to participants with normogly-,
Fig. 2. Difference in Z-scores of global gait and gait domains across different glycemic stages. The symbols represent the difference in Z-score of gait for participants with diabetes
(gray squares) and impaired fasting glucose (white triangles) compared to normoglycemia (black circles, reference). Error bars represent the 95% conﬁdence intervals around the
difference. Asterisks mark the associations that survived Bonferroni correction for 7 tests (p b 0.007). Model 1 is adjusted for age, sex, height, weight. Model 2 is additionally adjusted
for smoking, alcohol, mean diastolic blood pressure, mean systolic blood pressure, antihypertensive medication, total cholesterol, HDL-cholesterol, lipid lowering medication.
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Gait was mainly driven by the inclusion of antihypertensive
medication and total cholesterol into the analyses.
Impaired fasting glucose was not associated with Global Gait, nor
with any of the speciﬁc gait domains. However, for several domains
the effect estimates for impaired fasting glucose were between those
of diabetes and normoglycemia. This was especially noticeable for the
domains Pace and Tandem (Fig. 2).
Higher glucose levels were not associated with gait within
participants with normoglycemia nor within individuals with nor-
moglycemia or impaired fasting glucose combined (Table 2). There
were some indications for a non-linear relation of glucose with
Rhythm, Turning and Global Gait, but these associations did not survive
correction for multiple testing. We did not observe a consistent
pattern of effect modiﬁcation by sex in any of the analyses.
4. Discussion
In this population-based study diabetes mellitus was associated
with worse Global Gait, which was mainly accounted for by worse
Pace and Tandem. The association for Tandem remained signiﬁcant
after adjustment for cardiovascular risk factors. In persons with
impaired fasting glucose or a glucose level below the threshold for
diabetes there was no association with gait.
The strengths of our study include the large population-based
sample, assessment of both diabetes mellitus and earlier stages of
diabetes, deﬁned as impaired fasting glucose, and the extensive and
objective assessment of gait in different walking conditions using an
electronic walkway. Our study also has some limitations. The analyses
are cross-sectional, making it difﬁcult to draw ﬁrm conclusions on
causality. Gait was assessed in persons that visited the research
center, which might have prevented persons with severe physical
disability to participate, leading to a relatively healthy study
population. We did not have data on impaired glucose tolerance,
which is also part of the deﬁnition of prediabetes. Impaired glucose
tolerance may be stronger associated with complications of diabetes,
especially neuropathy, than impaired fasting glucose (Tabak et al.,2012). We were not able to assess how different diabetes treatment
types and diabetes duration would affect our results. This would be
interesting, since both insulin treatment and diabetes duration have
been associated with mobility impairment (Bruce, Davis, & Davis,
2005). Another limitation is that we did not evaluate the presence of
polyneuropathy, peripheral artery disease, diabetic feet and retinop-
athy and therefore were not able to assess how these conditions
inﬂuence the associations.
Gait is a complex motor function that depends on the interplay of
multiple systems, such as intact structure and functioning of the
central and peripheral nervous system, the vestibular system, intact
vascularization of both the brain and the extremities and intact
functioning of the musculoskeletal system. All of these systems can be
affected by diabetes. We found that participants with diabetes had
signiﬁcantly worse Global Gait, Pace and Tandem compared to persons
with normoglycemia. Previous, smaller studies that investigated the
association of diabetes with spatiotemporal variables of gait found an
association with a decrease in cadence (constituting the domain
Rhythm) (Allet et al., 2010, 2009; Ko, Hughes, & Lewis, 2012) and with
lower gait velocity and shorter stride length (both constituting the
domain Pace) (Allet et al., 2009, 2008; Kalyani et al., 2013; Ko et al.,
2012; Lalli et al., 2013; Raspovic, 2013; Sawacha, Guarneri, Avogaro, &
Cobelli, 2010; Sawacha et al., 2009; Volpato et al., 2012; Wrobel &
Najaﬁ, 2010). In our study, we also found an association with Pace,
which might result from damage to the vasculature of the legs or feet
or be due to damage of the proprioceptive system in case of
neuropathy. After adjusting for cardiovascular risk factors the
association with Pace attenuated, mainly due to inclusion of total
cholesterol and antihypertensive medications. Adjusting for cardio-
vascular risk factors also attenuated the association of diabetes with
Global Gait, suggesting that a large part of the effect of diabetes on gait
is due to vascular comorbidity.
Our study is among the ﬁrst to investigate the effect of diabetes
mellitus on tandem walk in a community-dwelling population. We
found a strong independent association of diabetes with errors in
tandemwalking. Tandemwalk represents a complex heel-to-toe type
of walk that requires very ﬁne and precise motor function, preserved
Table 2
Difference in Z-score of gait per mmol/L change in glucose level in people without diabetes.
Gait domains Normoglycemia, N = 1766 (serum glucose b5.6 mmol/L) Normoglycemia and impaired fasting glucose,
N = 2675 (serum glucose b7.0 mmol/L)
Model 1 Model 2 Model 1 Model 2
Global gait 0.05 (−0.06; 0.16) 0.04 (−0.07; 0.15) 0.02 (−0.04; 0.08) 0.01 (−0.06; 0.07)
Rhythm 0.05 (−0.06; 0.16) 0.03 (−0.08; 0.14) 0.03 (−0.03; 0.09) 0.02 (−0.05; 0.08)
Phases 0.09 (−0.01; 0.20) 0.10 (−0.01; 0.20) 0.06 (−0.00; 0.12) 0.06 (−0.00; 0.12)
Variability −0.02 (−0.13; 0.09) −0.03 (−0.15; 0.08) −0.04 (−0.11; 0.03) −0.05 (−0.12; 0.02)
Pace −0.07 (−0.17; 0.02) −0.10 (−0.20; −0.01) −0.05 (−0.10; 0.01) −0.06 (−0.12; −0.01)
Base of Support 0.03 (−0.08; 0.14) 0.04 (−0.07; 0.16) 0.06 (−0.01; 0.13) 0.06 (−0.01; 0.13)
Tandema −0.03 (−0.14; 0.08) −0.03 (−0.14; 0.08) −0.04 (−0.11; 0.03) −0.04 (−0.11; 0.03)
Turning 0.08 (−0.04; 0.20) 0.10 (−0.02; 0.22) 0.03 (−0.04; 0.10) 0.03 (−0.04; 0.11)
Values represent the difference in Z-score of gait with 1 mmol/L change in glucose level.
Model 1: age, sex, height, weight.
Model 2: model 1 + smoking, alcohol, mean diastolic blood pressure, mean systolic blood pressure, antihypertensive medication, total cholesterol, HDL-cholesterol, lipid lowering
medication.
None of the results survived Bonferroni adjustment for 7 tests (p-value = 0.007).
a Additionally adjusted for step length and step count in tandem walk.
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in order to be performed correctly. Even subtle changes in the feet and
lower limbs, as well as ocular pathology that can occur due to diabetes
mellitus may affect successful performance in tandem walk.
In our study, there was no association of diabetes with Rhythm. The
most likely explanation for this is that in our study cadence (Rhythm)
is made independent from stride length (Pace) with the principle
component analysis. Hence, associations with cadence in previous
studies may have been (partly) driven by an association with stride
length, which in our study is a component of Pace. Moreover, we
adjusted the analyses for several cardiovascular risk factors, which is
not performed inmost studies that found an effect on cadence (part of
the domain Rhythm). The results of these studies might have been due
to confounding. We did not ﬁnd an association of diabetes with
Variability, which is the domain from the normal walk that is
most strongly related to falls (Verlinden et al., 2014, 2013). Previous
studies that reported this association could only ﬁnd an effect while
walking in challenging circumstances or on irregular surface,
which makes comparison with our study difﬁcult (Allet et al., 2009,
2008). A perhaps surprising result was the inverted association of
diabetes with Phases, even though it did not survive correction
for multiple testing. Post-hoc analysis revealed that this was possibly
due to overadjustment for weight, which is a strong determinant
of both diabetes and Phases. Indeed, if we ran models without weight
as covariate, the effect size of diabetes for Phases was −0.17 (95%
CI −0.29; −0.04). This suggests that the association of diabetes
with “better” gait was likely a spurious result. Whether our ﬁndings
of gait impairment are speciﬁc to diabetes, or speciﬁc to certain
complications of diabetes such as polyneuropathy, needs to be
further investigated.
Since microvascular pathology occurs early in the development of
diabetes we hypothesized that this already leads to subtle changes in
gait characteristics in patients with earlier stages of diabetes.
However, in our study gait was not signiﬁcantly different in
participants with impaired fasting glucose than in participants with
normoglycemia, though we did ﬁnd a pattern of the strength of the
associations with impaired fasting glucose being in between those of
normoglycemia (reference) and diabetes. This suggests an early
decline in gait whenmoving away from the normal glucose range and
was especially noticeable in the domains Pace and Tandem. Yet, a
counterargument against this reasoning is the ﬁnding that a glucose
level within the normal range was not associated with gait domains
when investigated continuously.
To conclude, in our community-dwelling population, the presence
of diabetes mellitus was associated with worse Global Gait, Pace andTandem. This relationship is mainly mediated by cardiovascular risk
factors. Impairment in gait seems to occur early in the process of
developing diabetes mellitus. It may be beneﬁcial to detect and treat
abnormal fasting glucose levels and diabetes in early stages in order to
prevent future gait impairment in middle-aged and elderly people.
Furthermore, within diabetes care, tight regulation of blood pressure
and cholesterol levels might be important to prevent or reduce the
development of gait problems.Acknowledgment
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